Phase Ib INEOV Neoadjuvant Trial of Durvalumab +/- Tremelimumab with Platinum Chemotherapy for Patients (pts) with Unresectable Ovarian Cancer (OC): Survival Outcomes and Immune Correlates.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要